Berlin - Delayed Quote EUR

Quantum Biopharma Ltd. R (0K91.BE)

7.30
-0.20
(-2.67%)
As of 8:03:06 AM GMT+2. Market Open.
Loading Chart for 0K91.BE
  • Previous Close 7.50
  • Open 7.30
  • Bid 7.25 x --
  • Ask 7.55 x --
  • Day's Range 7.30 - 7.30
  • 52 Week Range 2.76 - 22.29
  • Volume 0
  • Avg. Volume 7
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 12, 2025 - Aug 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 0K91.BE

View More

Performance Overview: 0K91.BE

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

0K91.BE
90.10%
S&P/TSX Composite index (^GSPTSE)
4.71%

1-Year Return

0K91.BE
64.06%
S&P/TSX Composite index (^GSPTSE)
15.68%

3-Year Return

0K91.BE
87.00%
S&P/TSX Composite index (^GSPTSE)
28.26%

5-Year Return

0K91.BE
95.58%
S&P/TSX Composite index (^GSPTSE)
76.10%

Compare To: 0K91.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0K91.BE

View More

Valuation Measures

As of 5/14/2025
  • Market Cap

    2.15M

  • Enterprise Value

    -3.55M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.22

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0K91.BE

View More